跳至主要内容
临床试验/NCT02508935
NCT02508935终止4 期

A Phase 4, Open-Label Study of the Pharmacokinetics and Safety of XARTEMIS® XR (7.5 Oxycodone Hydrochloride/325 mg Acetaminophen) in Postsurgical Adolescent Subjects (Ages 12 to 17) With Moderate to Severe Acute Pain

Mallinckrodt2 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2015年11月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
终止
发起方
Mallinckrodt
入组人数
23
试验地点
2
主要终点
Time to Reach Steady State

研究概览

简要总结

Phase 4, multicenter, open-label, multiple-dose study of the pharmacokinetics (PK) and safety of XARTEMIS XR in postsurgical adolescent subjects aged 12 to 17 years with moderate to severe acute pain. The study will assess the safety of administering multiple doses of XARTEMIS XR in this population.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
12 Years 至 17 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

XARTEMIS XR

Experimental

All participants received XARTEMIS XR

干预措施: XARTEMIS XR (Drug)

结局指标

主要结局

Time to Reach Steady State

时间窗: within 60 hours

The time to reach steady state in participants who received all 5 doses

Area Under the Concentration-time Curve (AUC) From Time Zero (AUC0) to the Time of the Last Quantifiable Plasma Sample (AUClast)

时间窗: within approximately 12 hours (12.08 hours)

Elimination constant estimates required for the calculation of the planned AUC0-12 hours were not available. AUClast therefore provided the best available measure of exposure, effectively representing AUC0-12 hours for both moieties. While considered the best available measure, it also remains inaccurate because of the extended-release formulation and the lack of data beyond the 12.08-hour time point.

Maximum Observed Plasma Concentration (Cmax)

时间窗: within approximately 12 hours (12.08 hours)

The highest concentration of study drug within 12 hours.

Apparent Plasma Terminal Drug Elimination Half-life (T1/2)

时间窗: within approximately 12 hours (12.08 hours)

PK parameters are determined after a single administration of study drug on Day 1. Plasma concentrations that are below the level of quantification (BLQ) are set to 0 before Tmax, with the exception that a BLQ value occurring between measurable concentrations is set to missing. BLQ values that occur after Tmax are set to missing.

Time of Maximum Observed Plasma Concentration (Tmax)

时间窗: within approximately 12 hours (12.08 hours)

The time at which the maximum plasma concentration (Cmax) is reached.

次要结局

未报告次要终点

研究者

发起方
Mallinckrodt
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验